New Jersey · 222 session · house
A 4852Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*
- Status
- Passed chamber
- Latest action
- — Approved P.L.2026, c.40.
- Primary sponsor
- Katz, Andrea (Democratic)
- Bills and Joint Resolutions Signed by the Governor
Sponsors
- Katz, Andrea (Democratic) · primaryprimary
- Sweeney, Marisa (Democratic) · primaryprimary
- Kearney, Vincent M. · primaryprimary
- Tully, Chris (Democratic) · primaryprimary
- Vitale, Joseph F. · primaryprimary
- Gopal, Vin (Democratic) · primaryprimary
- Mukherji, Raj (Democratic) · primaryprimary
- Karabinchak, Robert J. (Democratic) · cosponsor
- Donlon, Margie, M.D. · cosponsor
Versions
- Introduced
- Assembly Committee Substitute—
- Statement—
Legislative history
- Approved P.L.2026, c.40.
- Received in the Senate without Reference, 2nd Reading
- Substituted for S4194/4210 (SCS)
- Passed by the Assembly (76-2-1)
- Passed Senate (Passed Both Houses) (38-2)
- Reported from Assembly Comm. as a Substitute, 2nd Reading
- Transferred to Assembly State and Local Government Committee
- Introduced, Referred to Assembly Health Committee
Official sources
About this page
- Is this the official New Jersey bill page?
- No — this is Billy’s public legislative record for A 4852. Official source links are listed above when publishers provide them.
- Can I track updates?
- Yes. Sign in to track A 4852, get alerts, annotate diffs, and export Word work product.